NeuroSense Therapeutics Ltd. (NRSN)

NASDAQ: NRSN · IEX Real-Time Price · USD

0.732

-0.029 (-3.76%)

At close: Jul 19, 2024, 4:00 PM

0.760

+0.028 (3.88%)

Pre-market: Jul 22, 2024, 6:54 AM EDT

NeuroSense Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-10.11	-10.11	-10.49	-3.22	-2.83	-1.22
Depreciation & Amortization	0.02	0.02	0.01	0	0	0
Share-Based Compensation	1.54	1.54	1.73	1.22	2.06	0.61
Other Operating Activities	0.2	0.2	1.14	0.46	0.07	0.03
Operating Cash Flow	-8.35	-8.35	-7.62	-1.54	-0.7	-0.58
Capital Expenditures	-0.03	-0.03	-0.07	-0.02	-0.01	-0.01
Change in Investments	3.5	3.5	-3.52	0	0	-0.02
Investing Cash Flow	3.47	3.47	-3.59	-0.02	-0.01	-0.03
Share Issuance / Repurchase	3.98	3.98	3.87	11.1	0.51	1.42
Debt Issued / Paid	0	0	0	0.8	0	-0
Other Financing Activities	-	-	-0.1	-	-	-
Financing Cash Flow	3.98	3.98	3.77	11.9	0.51	1.42
Exchange Rate Effect	0.01	0.01	-0.09	0.02	0	0
Net Cash Flow	-0.9	-0.9	-7.52	10.36	-0.2	0.81
Free Cash Flow	-8.38	-8.38	-7.69	-1.56	-0.7	-0.59
Free Cash Flow Per Share	-0.61	-0.61	-0.67	-0.25	-0.13	-0.13

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).